Development status: PLA-REGEN is under development and not yet CE-marked. Its regulatory classification is being defined with the competent authorities.
The product concept
What PLA-REGEN is
PLA-REGEN is a standardized, GMP-grade platelet preparation. Using the PTT process, it delivers a predefined, patient tailorable growth-factor profile that conventional autologous PRP cannot reliably reproduce.
It is supplied as a single, ready-to-use consumable kit with a fixed, validated composition — removing the batch-to-batch variability that limits PRP today.
PLA-REGEN vs. conventional PRP
Composition
Conventional PRP
Variable — donor and protocol dependent
PLA-REGEN
Standardized
Growth factor concentration
Conventional PRP
Highly variable (2–10× baseline)
PLA-REGEN
Consistently higher, process-controlled
Format
Conventional PRP
Prepared per patient, per session
PLA-REGEN
Single consumable kit — stockable
Commercial roadmap
One kit. Four application waves.
Wave 1 · Lead · Now
Aesthetic Medicine
Skin rejuvenation, hair restoration, anti-ageing. Large cash-pay market — fastest path to PLA-REGEN revenues.
Wave 2 · Expanding
Orthopaedics
Joint and soft-tissue repair. Strong clinical interest in PRP; PLA-REGEN offers a standardized, higher-potency option.
Wave 3 · Pipeline
Ophthalmology
Dry eye syndrome, corneal repair. High-value segment with clinical precedent for platelet-based preparations.
Wave 4 · Pipeline
Chronic Wound Care
Diabetic foot ulcers, venous leg ulcers. Large underserved population with significant unmet need.
Interested in PLA-REGEN?
We are exploring partnerships with aesthetic clinics, orthopaedic centres, distributors, and CDMOs.